rs113624356
Variant summary
The NM_024649.5(BBS1):c.1169T>G (p.Met390Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00268 (AC=4,322) in the gnomAD database across 1,614,180 control chromosomes, including 2 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.00329. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000373275: A homozygous knock-in mouse line carrying the Met390Arg variant showed a phenotype that included retinal degeneration, male infertility, and obesity (PMID:18032602)." and additional evidence is available in ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.M390V: Uncertain_significance (ClinVar VariationId 1979201, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_024649.5 missense
Scores
Clinical Significance
Conservation
Publications
- Bardet-Biedl syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women's Health, PanelApp Australia, Natera, Ambry Genetics, Genomics England PanelApp, G2P
- BBS1-related ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Likely_pathogenic. The variant received 9 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000373275: A homozygous knock-in mouse line carrying the Met390Arg variant showed a phenotype that included retinal degeneration, male infertility, and obesity (PMID: 18032602).; SCV001573536: Well-established functional studies show a deleterious effect (PS3).; SCV002058656: Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 12118255, 12677556, 22940089, 23143442).; SCV002503686: A knock-in mouse model homozygous for p.Met390Arg has cilia defects, and recapitulates aspects of the human BBS phenotype, including retinal degeneration, male infertility, and obesity (PMID: 18032602), and partial rescue (hypomorph) was demonstrated in a zebrafish assay (PMID: 20498079).; SCV000329106: Published functional studies demonstrate a damaging effect as mice homozygous for the M390R variant develop cilia defects, ventriculomegaly, retinopathy, and obesity (Davis et al., 2007);; SCV000253934: Experimental studies have shown that this missense change affects BBS1 function (PMID: 15314642, 18032602, 20498079).; SCV000699512: An in vivo BBS mouse model shows that mice homozygous for the M390R mutation recapitulate aspects of the human phenotype, including retinal degeneration, male infertility, and obesity (Davis_PNAS_2007).; SCV000712198: Animal models in mice have shown that this variant causes Bardet-Biedl syndrome (Davis 2007).; SCV003539679: Functional studies in zebrafish lacking BBS1 and co-injected with wildtype mRNA and this mutation demonstrated only a partial rescue, consistent with a possible hypomorphic effect of this variant (Zaghloul, 2010).; SCV004120938: "In vivo and in vitro studies suggest that this variant impacts protein function (Davis et al. 2007. PubMed ID: 18032602; Zaghloul et al. 2010. PubMed ID: 20498079)." | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (63/63 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_024649.5. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BBS1 | TSL:1 MANE Select | c.1169T>G | p.Met390Arg | missense | Exon 12 of 17 | ENSP00000317469.7 | Q8NFJ9-1 | ||
| ENSG00000256349 | TSL:2 | c.1280T>G | p.Met427Arg | missense | Exon 12 of 17 | ENSP00000398526.3 | Q8NFJ9-2 | ||
| BBS1 | TSL:1 | c.782T>G | p.Met261Arg | missense | Exon 9 of 13 | ENSP00000377563.2 | Q8NFJ9-3 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.00205 | AC:312 | Hom:0 | AN:152210 | Cov:32 |
GnomAD2 exomes | AF: 0.00151 | AC:380 | AN:251388 | ||
GnomAD4 exome | AF: 0.00274 | AC:4010 | Hom:2 | AN:1461852 | Cov:31 |
GnomAD4 genome | AF: 0.00205 | AC:312 | Hom:0 | AN:152328 | Cov:32 |
TOPMed (Bravo) | AF: 0.00210 | AC:556 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00223 | AC:1167 | Hom:1 | AN:522958 | |
Local & regional cohorts 5 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.00256 | AC:6 | Hom:0 | AN:2342 | |
Denmark Genome | AF: 0.00333 | AC:1 | AN:300 | ||
ESP6500 (Exome Variant Server) | AF: 0.00200 | AC:26 | AN:12990 | ||
GenomeAsia100K | AF: 0.000289 | AC:1 | AN:3478 | ||
UK10K | AF: 0.00357 | AC:27 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.00207 * | 23 | 11112 | 0.00199 * | 35 | 17618 |
BipEx | 0.00260 | 74 | 28420 | 0.00239 | 69 | 28844 |
Epi25 | 0.00186 | 78 | 41956 | 0.00232 | 155 | 66882 |
SCHEMA | 0.00169 | 206 | 121772 | 0.00248 | 474 | 190810 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.85 | |
BayesDel_addAF | Uncertain | 0.084 | D |
BayesDel_noAF | Pathogenic | 0.35 | |
CADD | Uncertain | 25 | |
DANN | Uncertain | 0.98 | |
DEOGEN2 | Uncertain | 0.75 | D |
Eigen | Uncertain | 0.49 | |
Eigen_PC | Uncertain | 0.49 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
GPN-Star LLR | N/A | -7.8 | |
GPN-Star score | N/A | 7.8 | |
LIST_S2 | Uncertain | 0.92 | D |
M_CAP | Uncertain | 0.12 | D |
MetaRNN | Benign | 0.081 | T |
MetaSVM | Uncertain | 0.73 | D |
Mutation Taster | N/A | 14/86 | disease causing (ClinVar) |
MutationAssessor | Uncertain | 2.2 | M |
PhyloP100 | Uncertain | 4.7 | |
popEVE | Benign | -4.1 | |
PrimateAI | Uncertain | 0.71 | T |
PROVEAN | Uncertain | -4.0 | D |
REVEL | Pathogenic | 0.66 | |
Sift | Uncertain | 0.012 | D |
Sift4G | Uncertain | 0.0080 | D |
Varity_R | N/A | 0.90 | |
VESM-3B | Benign | -15 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.010 | Details are displayed if max score is > 0.2 |
Splicevardb | N/A | 2.0 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.